Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Sale of 58,061 FDMT shares, $750.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 58,061 | $750.2K |
| Sep 16, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 58,333 | $811.0K |
| Aug 21, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Exercise/Conversion | 50,000 | $207.0K |
| Aug 5, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 26,842 | $274.6K |
| Aug 4, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 12,415 | $124.7K |
| Jul 14, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 42,608 | $548.2K |
| Jun 23, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 114,746 | $1.20M |
| Jun 2, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale | 1,922 | $19.3K |
| Mar 27, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 750,000 | n/a |
| Mar 10, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 267,500 | n/a |